Local Storage seems to be disabled in your browser.
For the best experience on our site, be sure to turn on Local Storage in your browser.

Difosfonal 300 mg 6 x 10 ml

Nr.
33090
Brand:
SPA - Società Prodotti Antibiotici
Batch:
2101
Expiry date:
30-Jun-2024

Clodronic acid

More info

DIFOSFONAL 300 mg / 10 ml concentrate for solution for infusion

Therapeutic Indications:

  • Tumor Osteolysis.
  • Multiple myeloma.
  • Primary hyperparathyroidism.
  • Prevention and treatment of postmenopausal osteoporosis.

Pharmacotherapeutic group: Drugs affecting bone structure and mineralization.

Clodronate is mainly excreted by the kidneys. Therefore, during the treatment with clodronate it is necessary to ensure adequate moisture absorption.

More Information
Nr.33090
Registration numberHuman
BrandSPA - Società Prodotti Antibiotici
Chilled itemNo
Active IngredientClodronate
Legal status of supplyPOM
Batch2101
Expiry dateJun 30, 2024
Units per outer box80
Ingredients

Clodronate disodium (Clodronic acid disodium salt) - 300mg / 10ml concentration for infusion solution

 

Instructions for use

DIFOSFONAL 300 mg / 10 ml concentrate for solution for infusion contains 54 mg sodium per dose. This medicine is for intravenous use only.
This should be taken into account when administering to patients with reduced kidney function or on a controlled sodium diet.

Veterinary advice

DIFOSFONAL is not recommended during pregnancy.

© 2021 Grovet B.V. All rights reserved.